Basic info
Industry
biotechnology research
Sectors
Biotechnology
Research and Development
Life Science
Therapeutics
Immuno-Oncology
Biopharma
CD47
Health Care
Innovation
Novel Biologics
Date founded
2015
Funding rounds raised
Total raised
$105M
from 11 investors over 11 rounds
A
ALX Oncology raised $100M on October 31, 2022
Investors: Oxford Finance LLC
A
ALX Oncology raised $105M on February 12, 2020
Investors: venBio Partners, Logos Global Management, LP, Lightstone Ventures, Vivo Capital and Foresite Capital
A
ALX Oncology raised $25M on March 31, 2017
Investors: venBio Partners and Lightstone Ventures
A
ALX Oncology raised $36M on March 18, 2015
Investors: The Longevity Fund, Lightstone Ventures and venBio Partners